1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising geriatric population and hormonal imbalance disorders
5.1.1.2. Growing awareness about menopausal signs and the treatment options
5.1.1.3. Rise in drug delivery systems for hormone therapy
5.1.2. Restraints
5.1.2.1. High cost of treatment
5.1.3. Opportunities
5.1.3.1. Introduction of bioidentical hormone replacement therapy
5.1.3.2. Innovative new launches of hormone replacement therapy
5.1.4. Challenges
5.1.4.1. Adverse health effects of hormone replacement therapy
5.2. Cumulative Impact of COVID-19

6. Hormone Replacement Therapy Market, by Type
6.1. Introduction
6.2. Estrogen Replacement Therapy
6.3. Growth Hormone Replacement Therapy
6.4. Thyroid Hormone Replacement Therapy

7. Hormone Replacement Therapy Market, by Route of Administration
7.1. Introduction
7.2. Oral
7.3. Parenteral
7.4. Transdermal

8. Americas Hormone Replacement Therapy Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Hormone Replacement Therapy Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand

10. Europe, Middle East & Africa Hormone Replacement Therapy Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abbott Laboratories
12.2. Amgen
12.3. Bayer
12.4. Eli Lily, LLC
12.5. Genentech
12.6. MED-EL
12.7. Merck & Co.
12.8. Mylan Laboratories
12.9. Novartis
12.10. Novo Nordisk, Wyeth
12.11. Pfizer

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL HORMONE REPLACEMENT THERAPY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL HORMONE REPLACEMENT THERAPY MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2020 VS 2027 (%)
FIGURE 4. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2020 VS 2027 (USD BILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2027
FIGURE 6. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN REPLACEMENT THERAPY, 2018-2027 (USD BILLION)
FIGURE 7. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN REPLACEMENT THERAPY, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 8. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GROWTH HORMONE REPLACEMENT THERAPY, 2018-2027 (USD BILLION)
FIGURE 9. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GROWTH HORMONE REPLACEMENT THERAPY, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 10. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THYROID HORMONE REPLACEMENT THERAPY, 2018-2027 (USD BILLION)
FIGURE 11. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THYROID HORMONE REPLACEMENT THERAPY, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 12. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2027 (%)
FIGURE 13. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2027 (USD BILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2027
FIGURE 15. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, 2018-2027 (USD BILLION)
FIGURE 16. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 17. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PARENTERAL, 2018-2027 (USD BILLION)
FIGURE 18. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PARENTERAL, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, 2018-2027 (USD BILLION)
FIGURE 20. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 21. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 22. ARGENTINA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 23. BRAZIL HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 24. CANADA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 25. MEXICO HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 26. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 27. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 28. AUSTRALIA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 29. CHINA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 30. INDIA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 31. INDONESIA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 32. JAPAN HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 33. MALAYSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 34. PHILIPPINES HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 35. SINGAPORE HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 36. SOUTH KOREA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 37. TAIWAN HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 38. THAILAND HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 39. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 40. FRANCE HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 41. GERMANY HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 42. ITALY HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 43. NETHERLANDS HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 44. QATAR HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 45. RUSSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 46. SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 47. SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 48. SPAIN HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 49. UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 50. UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 51. GLOBAL HORMONE REPLACEMENT THERAPY MARKET: FPNV POSITIONING MATRIX
FIGURE 52. GLOBAL HORMONE REPLACEMENT THERAPY MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 53. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL HORMONE REPLACEMENT THERAPY MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 4. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN REPLACEMENT THERAPY, BY REGION, 2018-2027 (USD BILLION)
TABLE 5. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GROWTH HORMONE REPLACEMENT THERAPY, BY REGION, 2018-2027 (USD BILLION)
TABLE 6. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THYROID HORMONE REPLACEMENT THERAPY, BY REGION, 2018-2027 (USD BILLION)
TABLE 7. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 8. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 9. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 10. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 11. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 12. ARGENTINA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 13. BRAZIL HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 14. CANADA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 15. MEXICO HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 16. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 17. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 18. AUSTRALIA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 19. CHINA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 20. INDIA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 21. INDONESIA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 22. JAPAN HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 23. MALAYSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 24. PHILIPPINES HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 25. SINGAPORE HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 26. SOUTH KOREA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 27. TAIWAN HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 28. THAILAND HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 30. FRANCE HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 31. GERMANY HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 32. ITALY HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 33. NETHERLANDS HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 34. QATAR HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 35. RUSSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 36. SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 37. SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 38. SPAIN HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 39. UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 40. UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 41. GLOBAL HORMONE REPLACEMENT THERAPY MARKET: SCORES
TABLE 42. GLOBAL HORMONE REPLACEMENT THERAPY MARKET: BUSINESS STRATEGY
TABLE 43. GLOBAL HORMONE REPLACEMENT THERAPY MARKET: PRODUCT SATISFACTION
TABLE 44. GLOBAL HORMONE REPLACEMENT THERAPY MARKET: RANKING
TABLE 45. GLOBAL HORMONE REPLACEMENT THERAPY MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 46. GLOBAL HORMONE REPLACEMENT THERAPY MARKET: MERGER & ACQUISITION
TABLE 47. GLOBAL HORMONE REPLACEMENT THERAPY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 48. GLOBAL HORMONE REPLACEMENT THERAPY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 49. GLOBAL HORMONE REPLACEMENT THERAPY MARKET: INVESTMENT & FUNDING
TABLE 50. GLOBAL HORMONE REPLACEMENT THERAPY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 51. GLOBAL HORMONE REPLACEMENT THERAPY MARKET: LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Amgen
Bayer
Eli Lily, LLC
Genentech
MED-EL
Merck & Co.
Mylan Laboratories
Novartis
Novo Nordisk, Wyeth
Pfizer